GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Tax Provision

Lavipharm (FRA:BXA0) Tax Provision : €4.36 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Tax Provision?

Lavipharm's tax provision for the six months ended in Jun. 2024 was €4.97 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2024 was €4.36 Mil.

Lavipharm Tax Provision Historical Data

The historical data trend for Lavipharm's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Tax Provision Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial 3.21 -1.21 -1.02 -1.31 -1.25

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.21 -1.10 -0.64 -0.61 4.97

Lavipharm Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lavipharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Tax Provision
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904 NBIX BOM:500124
Traded in Other Exchanges
LAVI:Greece
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Website
http://www.lavipharm.com
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines